2nd International Conference on Immunity and Immunochemistry

Aug 09-10, 2021

|

Barcelona, Spain



Welcome Message
“As we all know the Coronavirus disease 2019 (COVID-19) pandemic, brought about by extreme intense respiratory disorder Coronavirus 2 (SARS-CoV-2) has influenced a huge number of individuals around the world, touching off an unprecedented effort from mainstream researchers to comprehend the organic supporting of COVID19 pathophysiology. The immune system ensures against infections and sicknesses and produces antibodies to kill microbes.”
We’re delighted to welcome you to the 2nd International Conference on Immunity and Immunochemistry, taking place on August 09-10, 2021 in Barcelona, Spain. This event takes place over 2 days and will comprise plenary lectures, parallel sessions, poster sessions and our ever-popular ‘Workshop’ events, with something to suit all immunological and vaccines research. 
 
 About the Conference
Immunochemistry 2021 gives a profound impulse into the most recent discoveries and innovative headway in the field of Immunity and Immunochemistry. With individuals from around the globe focused in on finding out about Immunology and its advances; this is your best opportunity to arrive at the biggest array of members from the Immunology community. Widely acclaimed speakers, the latest   strategies, advancements, and the most up to date refreshes in Immunology are signs of this gathering.
 
The aim of the event is to host shows from far-famed specialists across the planet to harness the new collaborations in medical specialty, and medical specialty Sciences. Therefore, researchers within the relevant field will gift their analysis to debate the new results. rising sessions includes, young researchers forum and poster sessions providing likelihood to young participants to develop their career. Through the oral and poster displays, scientific sessions, and networking sessions, we tend to encourage dialogue between all the attendees to fill within the gaps to inspire innovative collaborations. 
 

Target Audience

  • Immunologists, Virologists, Microbiologists
  • Allergists, Pathologists, Biotechnologists
  • Physicians and Infectious diseases treatment doctors
  • University Professors
  • Research Labs
  • Various Societies Members
  • Research Scholars and Medical Students
  • Business Entrepreneurs
  • Manufacturing Medical Devices and Pharma Companies
  • Laboratory Technicians

Why to attend?

The attendees will notice exclusive sessions and panel discussions on the most recent innovations in Molecular medical specialty & Immunogenetics, be the first to showcase your analysis, innovation.

  • Lectures from noted speakers
  • Keynote forums by outstanding Professors and Directors
  • Open Innovation Challenges
  • Certification
  • Poster displays by Young Researchers
  • Global Networking sessions with 50+ Countries
  • Strengthening the network between the university, hospitals, research labs and pharma industries.
  • Summarize the studies of Immune System and targeting therapies to prevent coronavirus disease.
  • Discussing the latest findings and achievements in the treatment of Covid-19 through immunotherapies.

Market Scenario

Global Immune Health Supplements Market was valued at US$ 14.1 Bn in 2019 and is expected to reach US$ 24.7 Bn by 2027, at a CAGR of 7.26% during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market; same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The global immune health supplements market is driven by the increased awareness regarding the benefits of the immune health supplements among consumers. Increasing consumption of immune health supplements around the globe, which is anticipated to drive the immune health supplements market growth in the forecast period. The rise in chronic diseases around the globe, which is influencing the demand for immune health supplements. In addition, rising demand for the immune health supplements coupled with changing lifestyles of consumers across global, which is also estimated to fuel the global immune health supplements market growth in a positive way. Increased investments in R&D are driving the global immune health supplements market growth in a positive way. However, lack of awareness regarding immune health supplements among consumers is expected to hamper the global immune health supplements market growth in the forecast period.

COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025

The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the COVID vaccines market is attributed majorly to the rising number of people infected with COVID-19 and increasing funding for vaccine development.

On the other hand, the global COVID-19 drugs market is projected to reach USD 2 million by 2025 from USD 165 million in 2020, at a CAGR of -57.8% during the forecast period. The growth of the COVID drugs market is primarily attributed to use of repurposed drugs for compassionate use, and the emergence of alternative therapies such as convalescent plasma therapy which were earlier used for treating epidemic diseases such as SARS, MERS, and H1N1. Moreover, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies are fueling the market growth.

Currently, the R&D landscape for COVID-19 vaccines includes 115 vaccine candidates. The most advanced candidates that have recently moved into clinical development are:

  • mRNA-1273 from Moderna
  • Ad5-nCoV from CanSino Biologics
  • INO-4800 from Inovio
  • LV-SMENP-DC and pathogen-specific aAPC from Shenzhen Geno-Immune Medical Institute

Vaccine manufacturing ramp-up to drive the growth further
 

Currently, around 155 molecules are under clinical investigation, and about 45 molecules are under preclinical development to be targeted against COVID-19. In this list, four promising drugs have been repurposed for use against COVID-19.

Remdesivir
Chloroquine and hydroxychloroquine
Lopinavir and ritonavir (and that same combination plus interferon-beta)
An immune system messenger that can help stop the multiplication of viruses.

Lucy
Andrea Nicolini
Clinical Researcher
University of Pisa, Italy

Biography

Dr. Nicolini graduated (summa cum laude) at School of Medicine, University of Pisa in 1974. He received postgraduate diplomas at University of Pisa in Internal Medicine (1980), Pneumology (1984), and Nuclear Medicine (1986). His research interests include breast and gastrointestinal cancer and their metastases, tumour markers, post-operative follow-up, physiopathology, immunology and immunotherapy of cancer, and thyroid tumours.

Researches :

  • breast and gastrointestinal cancer
Lucy
Lyudmyla Symochko
Associate Professor
Institute of Agroecology and Environmental Management
Uzhhorod National University, Ukraine

Biography

Symochko Lyudmya is a specialist in environmental microbiology and soil ecology. Since 2008 she has focused on autecology and synecology researches of soil microbiota. She explores the soil resistome and the role of natural and transformed ecosystems as reserves of antibiotic-resistant microorganisms. She developing and improving existing methods of bioindication and biotesting the edaphotops in different biogeocenosis. She is an author of over 120 scientific publications and 55 in professional journals.

Researches :

  • soil resistome and human health
Lucy
Ahmed Hegazi
Professor
Microbiology and Immunology
National Research Center, Egypt

Biography

Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979 and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects. Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 222 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals. Dr. Hegazi is also the president of the Egyptian Environmental Society for Uses and Production of Bee Products, secretary of the Egyptian Society of Apitherapy, secretary general of the African Federation of Apiculture Associations, and a member of the International Apitherapy Commission (APIMONDIA).

Researches :

  • Prof. Hegazi's research work has been focused lately on bee products and their therapeutic effects.
Lucy
Aaron Lerner
Professor
Aesku.Kipp Institute. Wendelsheim, Germany

Biography

After receiving his MD from the Sakler school of medicine, Tel-Aviv University (1976), Professor Lerner  specialized in Pediatrics ( 1982 ), Pediatric Gastroenterology and Nutrition (  1984 ) and Adult Gastroenterology ( 1987).  Took several senior positions as head of Department of pediatrics (1995-2005) and head of Pediatric Gastroenterology and Nutrition unit, at the Carmel Medical Center, Haifa, Israel. Finished his Medical Management degree M.H.A, at Ben- Gurion University, Beer-Sheba, Israel (1999), spent research sabbaticals in Hahnemann University, Philadelphia, PA, USA (1991), State University of North Carolina, Chapel Hill, N.C, U.S.A (2005) and currently, involved In scientific projects in Aesku.Kipp Institute, Wendelsheim, Germany.(2014-2020). 

Researches :

  • pathogenesis, diagnosis and treatment of systemic autoimmune diseases (ADs) in particular gastrointestinal conditions and pediatric nutrition, nutritional assessment and deficiencies, celiac and Crohn’s diseases
Lucy
Gisele Picolo
Director
Laboratory of Pain and Signaling
Butantan Institute, São Paulo, Brazil

Biography

Gisele Picolo graduated in Biology, obtained her master degree in Experimental and Comparative Pathology and her PhD in the field of Pharmacology. She is currently researcher at Butantan Institute and Director of the Laboratory of Pain and Signaling. She acts as principal investigator at the Center for toxins, immune response and cell signaling (CeTICS, Brazil) and as a collaborative researcher at the Center of excellence in the discovery of new molecular targets (CENTD, Brazil). She acts in the areas of Pathophysiology and Pharmacology, acting mainly on the following themes: pain and inflammation, analgesia, animal poisons and toxins, and in the search for new analgesic compounds. She was awarded with the IASP Developing Countries Collaborative Research Grants, offered by the International Association for the Study of Pain in 2016, and awarded among the 5 best works in chronic pain during the 6th International Congress on Neuropathic Pain, Sweden, 2017. She is member of the National Commission for the Organization of the Brazilian Biology Olympics since 2018. She authored more than 45 publications (scientific articles, reviews, monographs, book chapters). She has 4 patents applied as inventor in the area of analgesics.

Researches :

  • Pathophysiology and Pharmacology
Lucy
K M Yacob
Chief Physician
Marma Health Centre, India

Biography

K. M. Yacob is a practicing physician in the field of healthcare in the state of Kerala in India for the last 31years and very much interested in basic research. His interest is spread across the fever, inflammation and back pain. He is a writer and already printed and published nine books on these subjects. He wrote hundreds of articles in various magazines. After scientific studies, he has developed 8000 affirmative cross checking questions. It  can explain all queries related to fever.

Researches :

  • fever, inflammation and back pain
Lucy
Carol Apt
Professor
South Carolina State University, USA

Biography

Carol Apt has received her PhD in Sociology from Northeastern University in Boston, Massachusetts, her Master's Degree in Sociology from Boston University in Boston, Massachusetts, and her Bachelor's Degree in Sociology from Indiana University in Indianapolis, Indiana. She also has a certificate of French Studies from Ecole Lemania in Lausanne, Switzerland. She is a Professor of Sociology and the Coordinator of the Sociology Program at South Carolina State University in Orangeburg, South Carolina, where she has been for 20 years. She teaches courses in Human Sexuality, Medical Sociology, Social problems, and the Sociology of Genocide. In 2011, she was honored as the South Carolina State University Professor of the Year. She is a Member of several Editorial Boards and is a Consulting Member of the South Carolina Medical Association Bioethics Committee. In addition to her experience as an author and newspaper and magazine columnist, she is the host of a live, call-in talk radio show entitled, "Talk to Me," which addresses issues of sexuality and relationships. It is broadcast on 90.3 FM, WSSB, an NPR affiliate.

Researches :

  • Human Sexuality, Medical Sociology, and Social problems
Lucy
El Hadji Seydou Mbaye
Professor
International Agency for Research on Cancer, France

Biography

Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).

Researches :

  • Virology and Biochemistry
Lucy
Huang Wei Ling
Medical Nutrition Therapist
Medical Acupuncture and Pain Management Clinic

Biography

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.

Researches :

  • chronic diseases and Infection control
Lucy
John Miles
Principal Research Fellow
Institute of Tropical Health and Medicine
James Cook University

Biography

Professor John Miles is Principal Research Fellow of Molecular Immunology at the Australian Institute of Tropical Health and Medicine, James Cook University, Australia. He is co-director for the Centre for Tropical Bioinformatics and Molecular Biology and theme leader for the Centre for Molecular Therapeutics at James Cook University. Professor Miles is an expert in human immune system monitoring and modulation, where he has published 117 papers (h-index 44 and 6,700 citations), I am in the 100th percentile in percentile by my worldwide Topic of Cluster Prominence in my field of T cell biology.

Researches :

  • Molecular Biology and Molecular Therapeutics

Program Overview

Our Collaborations, Sponsors, Media Partners